indignant
发表于 2025-3-23 11:16:16
http://reply.papertrans.cn/83/8285/828461/828461_11.png
粗野
发表于 2025-3-23 15:37:53
2196-5501 s used to treat ER+ or Her2+ breast cancers (i.e. Tamoxifen .We present an in-depth description of resistance to targeted therapies in breast cancer. Targeted therapies discussed here include those used to treat ER+ or Her2+ breast cancers (i.e., Tamoxifen or trastuzumab) or those targeting signalin
MEET
发表于 2025-3-23 20:14:38
http://reply.papertrans.cn/83/8285/828461/828461_13.png
Incumbent
发表于 2025-3-23 23:03:02
http://reply.papertrans.cn/83/8285/828461/828461_14.png
STENT
发表于 2025-3-24 05:52:51
http://reply.papertrans.cn/83/8285/828461/828461_15.png
牛马之尿
发表于 2025-3-24 10:11:17
Targeting FGFR for the Treatment of Breast Cancer,candidates for any currently approved molecular therapies and they are left with suboptimal, highly cytotoxic chemotherapies as treatment options. Therefore, recent research has focused on identifying the molecular drivers of TNBC and metastatic breast cancer that has undergone subtype switching and
绊住
发表于 2025-3-24 11:22:17
Targeted Therapies in Breast Cancer,th increased cell proliferation and mammosphere production, while inhibition has been shown to minimize these effects in cancerous cells. The PI3K pathway is an essential component of intracellular signaling that is frequently dysregulated in tumors. Poly(ADP-ribose) polymerases (PARP) are implicate
为敌
发表于 2025-3-24 17:18:13
Future Paradigm of Breast Cancer Resistance and Treatment, a resistant cell. One of the examples of these molecularly targeted biomarker therapies in HER2/neu-positive breast cancer is HER2/neu blockage. Following endocrine therapy, the occurrence of secondary resistance, such as ESR1 mutations, poses a significant challenge. Drugs like lapatinib may be ef
白杨
发表于 2025-3-24 22:02:23
http://reply.papertrans.cn/83/8285/828461/828461_19.png
地壳
发表于 2025-3-25 00:31:04
http://reply.papertrans.cn/83/8285/828461/828461_20.png